Status | Study |
Active, not recruiting |
Study Name: Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis B-cell Chronic Lymp Date: 2014-01-14 Interventions: Drug: bortezomib Given IV |
Completed |
Study Name: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Ex Date: 2013-10-08 Interventions: Drug: busulfan Given IV |
Active, not recruiting |
Study Name: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma Condition: Adult Grade III Lymphomatoid Granulomatosis Cutaneous B-cell No Date: 2013-03-19 Interventions: Biological: autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T |
Active, not recruiting |
Study Name: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Ex Date: 2013-02-27 Interventions: Drug: brentuximab vedotin Give |
Recruiting |
Study Name: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Ex Date: 2013-02-13 Interventions: Other: questionnaire administration |
Recruiting |
Study Name: Tissue Collection for Studies of Lymph Cancer Condition: Hodgkin Disease Lymphoma, Non-Hodgkin Multiple Myeloma Date: 2012-08-29 |
Active, not recruiting |
Study Name: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2012-02-06 Interventions: Drug: fludarabine phosphate Gi |
Terminated |
Study Name: Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma Condition: Adult Acute Lymphoblastic Leukemia in Remission Adult Grade III Lympho Date: 2011-08-01 Interventions: Drug: plerixafor Given SC |
Completed |
Study Name: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Ex Date: 2010-07-07 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Terminated |
Study Name: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma Condition: Adult Non-Hodgkin Lymphoma Adult Grade III Lymphomatoid Granulomatosis Date: 2010-01-08 Interventions: Drug: lenalidomide Given orall |